PGN-EDO51
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PGN-EDO51, covering 2025-06-24 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment [Phase 2]